H1B Report
Side-by-side comparison

Albany Molecular Research, Inc. vs Deloitte Consulting LLP

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity B
Deloitte Consulting LLP
PARank #4FEIN 06-1454513

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricAlbany Molecular Research, Inc.Deloitte Consulting LLP
Total filings14880,813
Certified %93.24%98.23%
Denied %1.35%1.09%
Withdrawn %2.03%0.61%
Cert-withdrawn %3.38%0.07%
Rank#4
Active yearsFY2010–FY2019FY2010–FY2026
Worksite stateNYPA

Outcomes — Albany Molecular Research, Inc.

DOL case-status mix.

Outcome breakdown: Certified 93.2%, Cert-withdrawn 3.4%, Withdrawn 2.0%, Denied 1.4%
Outcome breakdown
OutcomeShare
Certified93.2%
Cert-withdrawn3.4%
Withdrawn2.0%
Denied1.4%
Certified93.2%
Cert-withdrawn3.4%
Withdrawn2.0%
Denied1.4%

Outcomes — Deloitte Consulting LLP

DOL case-status mix.

Outcome breakdown: Certified 98.2%, Cert-withdrawn 0.1%, Withdrawn 0.6%, Denied 1.1%
Outcome breakdown
OutcomeShare
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Albany Molecular Research, Inc.
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY201012
FY201120
FY201214
FY20139
FY20149
FY20159
FY201617
FY201716
FY201815
FY201927
FY20200
FY20210
FY20220
FY20230
FY20240
FY20250
FY20260
Deloitte Consulting LLP
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20102,375
FY20113,610
FY20124,716
FY20136,082
FY20147,007
FY20157,572
FY20167,629
FY20177,147
FY201816,089
FY20197,754
FY202052
FY202135
FY202211
FY20231,134
FY20242,702
FY20254,286
FY20262,612

Top 5 occupations — Albany Molecular Research, Inc.

Top 5 occupations — Deloitte Consulting LLP

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.